首页> 外国专利> Compositions and procedures for lymphocyte activation of monocytic dendritic cells and T cells to generate a Th-1 response

Compositions and procedures for lymphocyte activation of monocytic dendritic cells and T cells to generate a Th-1 response

机译:单核细胞树突状细胞和T细胞产生Th-1反应的淋巴细胞活化的组成和程序

摘要

An ex vivo or in vitro procedure for producing activated T cells comprising: contacting the provided immature dendritic cells with an amount of Bacillus Calmette-Guerin (BCG) consisting of between 105 and 107 cfu per ml of tissue culture medium and between 100 and 1000 units of interferon gamma (IFNγ) per ml of tissue culture medium and a predetermined antigen under culture conditions suitable for the maturation of immature dendritic cells, in order to form mature dendritic cells or a population of mature dendritic cells ; where the mature dendritic cell population produces at least 10 times more interleukin 12 than interleukin 10 than a similar dendritic cell population grown in the presence of BCG without IFNγ, and contacting the mature dendritic cells with naïve T cells to form activated T cells that produce IFNγ, and where activated T cells produce a type 1 immune response.
机译:用于产生活化的T细胞的离体或体外方法,包括:使提供的未成熟树突细胞与一定量的卡介苗芽孢杆菌(BCG)接触,每毫升组织培养基中含有105至107 cfu,100至1000单位之间在适合于未成熟树突状细胞成熟的培养条件下,每毫升组织培养基和预定抗原中的干扰素γ(IFNγ),以形成成熟的树突状细胞或成熟的树突状细胞群;其中成熟树突细胞群产生的白细胞介素12较白细胞介素10高至少10倍于在没有IFNγ的BCG存在下生长的相似树突细胞群,并使成熟树突细胞与幼稚T细胞接触以形成产生IFNγ的活化T细胞,以及活化的T细胞产生1型免疫反应的位置。

著录项

  • 公开/公告号ES2766299T3

    专利类型

  • 公开/公告日2020-06-12

    原文格式PDF

  • 申请/专利权人 NORTHWEST BIOTHERAPEUTICS INC.;

    申请/专利号ES10181985T

  • 发明设计人 BOSCH MARNIX;

    申请日2002-09-06

  • 分类号A61K39;A61K45;A61P37/04;C07K14/54;C12N;C12N5;C12N5/02;C12N5/0784;G06K19;

  • 国家 ES

  • 入库时间 2022-08-21 11:15:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号